-
Johnson & Johnson settlement will be over $6.4B for ovarian cancer lawsuitsMay 1, 2024 -
J&J to end global sales of talc-based powder amid lawsuits, cancer concernsAugust 12, 2022 -
FDA restricts J&J's COVID-19 vaccine due to blood clot riskMay 5, 2022 -
Who will be eligible this week for a 4th COVID shot?January 12, 2022 -
J&J vaccine may work best as a Pfizer booster, new study showsDecember 6, 2021 -
South African scientists detect new virus variant amid spikeNovember 25, 2021 -
Lower rate of booster shots in hard-hit areas of L.A., health officials sayNovember 23, 2021 -
Pfizer asks FDA to OK COVID-19 booster shots for all adultsNovember 9, 2021 -
US gives final clearance to COVID-19 shots for kids 5 to 11November 2, 2021 -
O.C. Judge sides with drug companies in California opioid crisis lawsuitNovember 2, 2021